logo image
search icon
Insulin-like Growth Factors Market

Insulin-like Growth Factors Market Share & Trends Analysis Report, By Type (Mechano Growth Factor, Somatomedin C, IGF 1), By End-user (Hospitals, Medical Centers), By Region, and Segment Forecasts, 2023-2031

Report ID : 2561 | Published : 2024-07-04 | Pages: 180 | Format: PDF/EXCEL

Insulin-like Growth Factors Market Size is valued at USD 275.1 Mn in 2023 and is predicted to reach USD 406.1 Mn by the year 2031 at an 5.13% CAGR during the forecast period for 2024-2031.

insulin like growth factor market info

Insulin-like growth factors (IGFs) are proteins that resemble insulin in structure and share some of its effects. Their primary function, however, is to stimulate cell growth and development throughout the body, forming part of a complex system known as the IGF axis. There are two main types of IGFs: IGF-1 and IGF-2. IGF-1 is a hormone that mediates the effects of growth hormone (GH) in the body. Together, IGF-1 and GH promote the normal growth of bones and tissues. Unlike GH levels, which fluctuate throughout the day based on diet and activity levels, IGF-1 levels remain relatively stable. Therefore, an IGF-1 test is a valuable tool for determining if the body is producing a normal amount of GH. IGFs play a significant role in muscle growth and repair. They enhance protein synthesis and muscle cell proliferation, making them important for muscle recovery and strength. IGFs are crucial for normal growth and development, particularly during childhood and adolescence. They stimulate the growth of bones and tissues, ensuring proper physical development.

IGF levels vary with age. They are typically highest during childhood and adolescence, supporting rapid growth and development. Levels decline with age, contributing to the decreased regenerative capacity seen in older adults. Regular exercise can enhance IGF-1 levels, particularly resistance training and high-intensity interval training (HIIT). Physical activity stimulates muscle growth and repair, processes in which IGFs play a critical role.

Competitive Landscape

Some of the Major Key Players in the Insulin-like Growth Factors Market are

  • Boehringer Ingelheim International GmbH
  • Genervon Biopharmaceuticals LLC
  • Ascendis Pharma
  • Regulaxis SAS
  • MedImmune, LLC
  • Other Prominent Players

Market Segmentation:

The is segmented based on by type, by end-user, and by region. Based on the by type, the segment is divided into mechano growth factor, somatomedin C, and IGF 1. Based on the end user, the market segment is divided into hospitals and medical centers.

The IGF-1 Segment is Expected to have growth rate during the forecast period

Based on the type, the market segment is divided into the mechano growth factor, somatomedin C, and IGF 1. Among these, the IGF-1 segment is expected to have growth rate during the forecast period. IGF-1 has a clearer and more established role in the body compared to IGF-2. IGF-1 is known to be crucial for growth and development throughout life, impacting bones, muscles, and organs. IGF-1 has a wide range of clinical applications, making it a highly sought-after therapeutic agent. It is used in treating growth hormone deficiencies, chronic conditions like diabetes, muscle wasting diseases, and certain forms of dwarfism. Its broad therapeutic potential drives significant demand in the market.

The Hospitals Segment Dominate the Market

The end-user segment is categorized into hospitals and medical centers. Among these, the hospital segment dominates the market. Hospitals are primary sites for administering IGF-based therapies. These institutions handle the diagnosis and treatment of growth hormone deficiencies, chronic conditions, and other medical issues that require IGF therapies. Their role in providing specialized medical care makes them crucial players in the IGF market. Hospitals often serve as hubs for clinical research and trials. These institutions conduct studies on IGF-1's efficacy and safety for various conditions, contributing to advancements in IGF-based treatments and boosting market growth.

North America is the Fastest-Growing Region During the Forecast Period.

North America is expected to expand at the highest rate.  The region faces a significant burden of chronic diseases like diabetes, cancer, and chronic kidney disease. These conditions are often associated with impaired growth factor signaling, and IGFs are being explored as potential therapeutic agents. The regulatory environment in North America might be more streamlined compared to some other regions, potentially facilitating faster approval of IGF-based therapies.  North America has a high level of healthcare spending compared to other regions. This allows for greater investment in research, development, and adoption of new technologies and treatments, including IGF-based therapies.

Recent Developments:

  • In Aug 2021, Ascendis Pharma A/S, a biopharmaceutical company, confirmed that the US Food and Drug Administration (FDA) has approved SKYTROFA (lonapegsomatropin-tcgd) for the treatment of pediatric patients aged one year and up who weigh at least 11.5 kg (25.4 lb) and have growth failure caused by insufficient secretion of endogenous growth hormone (GH). The company's cutting-edge TransCon technologies might lead to the development of new medicines that have a significant impact on patients' lives.

Insulin-like Growth Factors Market Report Scope

Report Attribute

Specifications

Market Size Value In 2023

USD 275.1 Mn

Revenue Forecast In 2031

USD 406.1 Mn

Growth Rate CAGR

CAGR of 5.13% from 20242031

Quantitative Units

Representation of revenue in US$ Bn and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Type, By end user, By Region

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; South East Asia

Competitive Landscape

Boehringer Ingelheim International GmbH, Genervon Biopharmaceuticals LLC, Ascendis Pharma, Regulaxis SAS, MedImmune, LLC

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Insulin-like Growth Factors Market Snapshot

Chapter 4. Global Insulin-like Growth Factors Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis

5.1. by Type & Market Share, 2019 & 2031

5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type:

5.2.1. Mechano Growth Factor

5.2.2. Somatomedin C

5.2.3. IGF 1

Chapter 6. Market Segmentation 2: by End-users Estimates & Trend Analysis

6.1. by End-users & Market Share, 2019 & 2031

6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-users:

6.2.1. Hospitals

6.2.2. Medical Centers

Chapter 7. Insulin-like Growth Factors Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031

7.1.2. North America Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2024-2031

7.1.3. North America Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

7.2. Europe

7.2.1. Europe Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031

7.2.2. Europe Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2024-2031

7.2.3. Europe Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

7.3. Asia Pacific

7.3.1. Asia Pacific Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031

7.3.2. Asia Pacific Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2024-2031

7.3.3. Asia Pacific Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

7.4. Latin America

7.4.1. Latin America Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031

7.4.2. Latin America Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2024-2031

7.4.3. Latin America Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

7.5. Middle East & Africa

7.5.1. Middle East & Africa Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031

7.5.2. Middle East & Africa Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2024-2031

7.5.3. Middle East & Africa Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. Boehringer Ingelheim International GmbH

8.2.2. Genervon Biopharmaceuticals LLC

8.2.3. Ascendis Pharma

8.2.4. Regulaxis SAS

8.2.5. MedImmune, LLC

8.2.6. Other Prominent Players

Segmentation of Insulin-like Growth Factors Market

Global Insulin-like Growth Factors Market, By Type

  • Mechano Growth Factor
  • Somatomedin C
  • IGF 1

insulin like growth factor market seg

Global Insulin-like Growth Factors Market – By End-user

  • Hospitals
  • Medical Centers

Global Insulin-like Growth Factors Market – By Region

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Insulin-like Growth Factors Market Size?

Insulin-like Growth Factors Market is predicted to develop at an 5.13% CAGR during the forecast period for 2024-2031.

Boehringer Ingelheim International GmbH, Genervon Biopharmaceuticals LLC, Ascendis Pharma, Regulaxis SAS, MedImmune, LLC

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach